Koguchi Dai, Matsumoto Kazumasa, Ikeda Masaomi, Taoka Yoshinori, Hirayama Takahiro, Murakami Yasukiyo, Utsunomiya Takuji, Matsuda Daisuke, Okuno Norihiko, Irie Akira, Iwamura Masatsugu
Department of Urology, Kitasato University School of Medicine, Kanagawa 252-0374, Japan.
Department of Urology, Kitasato University Medical Center, Saitama 364-8501, Japan.
Jpn J Clin Oncol. 2019 Apr 1;49(4):373-378. doi: 10.1093/jjco/hyz015.
The prognostic value of histologic variants (HV) after radical cystectomy (RC) remains controversial. We evaluated the clinicopathological features and prognosis in patients with pure urothelial carcinoma (UC) and HV following RC.
From 1990 to 2015, 286 patients with bladder cancer were treated with RC at six Kitasato University-affiliated hospitals. All patients were divided into two groups: pure UC and HV, which contained pure variants and mixed-type UC with variant pattern. A comparison of patient characteristics between the two groups was made to assess the clinicopathological features, and statistical analyses were performed to investigate prognosis in the two groups.
Of the 286 patients, 226 (79%) had pure UC, while 60 (21%) had HV. Of all HV, pure variants accounted for 45% (n = 27). The prevalence of lymph node involvement, locally advanced stage (≥ pT3), positive soft tissue surgical margin and lymphovascular invasion were significantly higher in patients with HV than in those with pure UC. Patients with HV showed worse disease-free survival and cancer-specific survival than those with pure UC (P = 0.009 and 0.003, respectively). In multivariate analysis, HV and lymph node involvement were independent predictors of worse disease-free survival (P = 0.017 and 0.001, respectively). HV, locally advanced stage, lymph node involvement, and positive soft tissue surgical margin were also confirmed as independent predictors of worse cancer-specific survival (P = 0.011, 0.012, 0.003 and 0.010, respectively.).
HV was associated with greater biological aggressiveness and worse prognosis than pure UC.
根治性膀胱切除术后组织学变异型(HV)的预后价值仍存在争议。我们评估了根治性膀胱切除术后纯尿路上皮癌(UC)和HV患者的临床病理特征及预后。
1990年至2015年,286例膀胱癌患者在北里大学附属的六家医院接受了根治性膀胱切除术。所有患者分为两组:纯UC组和HV组,HV组包含纯变异型和具有变异模式的混合型UC。比较两组患者的特征以评估临床病理特征,并进行统计分析以研究两组的预后。
286例患者中,226例(79%)为纯UC,60例(21%)为HV。在所有HV中,纯变异型占45%(n = 27)。HV患者的淋巴结受累、局部晚期(≥ pT3)、软组织手术切缘阳性和淋巴管浸润的发生率显著高于纯UC患者。HV患者的无病生存期和癌症特异性生存期均比纯UC患者差(分别为P = 0.009和0.003)。多因素分析中,HV和淋巴结受累是无病生存期较差的独立预测因素(分别为P = 0.017和0.001)。HV、局部晚期、淋巴结受累和软组织手术切缘阳性也被确认为癌症特异性生存期较差的独立预测因素(分别为P = 0.011、0.012、0.003和0.010)。
与纯UC相比,HV具有更高的生物学侵袭性和更差的预后。